Winter itch
Methodology & AI Transparency ⓘ
Winter itch Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Cataloged under federal diagnostic code L29.89 in Skin & Dermatology, Winter itch requires topical retinoids/calcineurin/steroid sparing in Winter itch (L29.89: regimens) so specialists can calibrate treatment intensity against Fasting Lipids & in Winter itch (L29.89: ALT (if systemic) benchmarks.
- 2 Real-world patient consensus: Diagnostic registry L29.89: Winter itch is managed within Skin & Dermatology.
- 3 Typical cash cost range: Differential triage of Winter itch (L29.89) utilizes topical retinoids/calcineurin/steroid sparing in Winter itch (L29.89: regimens).
- 4 Top reported side effects / signs: Key Skin & Dermatology biomarkers for Winter itch (L29.89): Fasting Lipids & in Winter itch (L29.89: ALT (if systemic) & 25-Hydroxy Vitamin D in Winter itch (L29.89: & hs-CRP) (25(OH)D 40–65 ng/mL (L29.89)).
Ask our AI Specialists anything about Winter itch
What Is Winter itch?
Cataloged under federal diagnostic code L29.89 in Skin & Dermatology, Winter itch requires topical retinoids/calcineurin/steroid sparing in Winter itch (L29.89: regimens) so specialists can calibrate treatment intensity against Fasting Lipids & in Winter itch (L29.89: ALT (if systemic) benchmarks.
Pathophysiology, Underlying Causes & Clinical Presentation
Winter itch (L29.89) alters skin & dermatology homeostasis through cutaneous immune skewing in Winter itch (L29.89: (Th2/IL-4/IL-13 in atopic); clinical remission targets 25-Hydroxy Vitamin D in Winter itch (L29.89: & hs-CRP) within 25(OH)D 40–65 ng/mL (L29.89).
Common Symptoms & Clinical Signs
- • Presentation of Winter itch (L29.89): compromised epidermal barrier in Winter itch (L29.89: with dryness, fissuring,)
- • Secondary Winter itch clinical sign: post-inflammatory hyperpigmentation, facial in Winter itch (L29.89: flushing, or pitted)
- • Symptom flares in Winter itch correlating with Fasting Lipids & in Winter itch (L29.89: ALT (if systemic) deviation outside Within baseline reference limits (L29.89)
- • Functional skin & dermatology impact requiring topical retinoids/calcineurin/steroid sparing in Winter itch (L29.89: regimens) evaluation (L29.89)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Winter itch Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | L29.89 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Dermatology: Acne, Eczema, Psoriasis & Rosacea | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Fasting Lipids & in Winter itch (L29.89: ALT (if systemic) | Within baseline reference limits (L29.89) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: 25-Hydroxy Vitamin D in Winter itch (L29.89: & hs-CRP) | 25(OH)D 40–65 ng/mL (L29.89) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Affected Body Surface in Winter itch (L29.89: Area (BSA /) | Clear or Almost Clear (IGA 0–1) (L29.89) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Winter itch
Treatment selection for Winter itch depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Winter itch)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Effect of tralokinumab on moderate-to-severe eczema in patients with atopic Regardless of the presence or number of self-reported atopic comorbidities, 16 weeks of tralokinumab treatment improved AD severity in adults and adolescents. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology • 2025-10-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 40555305 ↗ |
| Can This Approach Help? Inside the Latest Research on Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in In two phase 3 clinical trials, fixed-dose, triple-combination CAB demonstrated good efficacy/safety. Journal of drugs in dermatology : JDD • 2024-11-01 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 39496135 ↗ |
| Can This Approach Help? Inside the Latest Research on A randomized, investigator-blinded trial to assess the antimicrobial efficacy of These data suggest that clindamycin phosphate 1%/benzoyl peroxide 5% gel reduces P. Journal of drugs in dermatology : JDD • 2010-02-15 • Randomized Controlled Trial | Multi-cohort | 82/100 | PMID 20214175 ↗ |
Winter itch Patient Community & “People Like Me” Threads
Filter Winter itch community threads and patient logs by age, biological sex, dosage, and treatment duration.